Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Teng YC, Shen ZQ, Kao CH, Tsai TF.

World J Gastroenterol. 2016 Jan 7;22(1):300-25. doi: 10.3748/wjg.v22.i1.300. Review.

2.

Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-Κb P65 and Wnt/Β-Catenin in Vitro.

Li J, Dai W, Xia Y, Chen K, Li S, Liu T, Zhang R, Wang J, Lu W, Zhou Y, Yin Q, Abudumijiti H, Chen R, Zheng Y, Wang F, Lu J, Zhou Y, Guo C.

Mar Drugs. 2015 Sep 24;13(10):6064-81. doi: 10.3390/md13106064.

3.

AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma.

Cui Y, Lin C, Wu Z, Liu A, Zhang X, Zhu J, Wu G, Wu J, Li M, Li J, Song L.

Oncotarget. 2014 Dec 15;5(23):12057-69.

4.

Role of estrogen in hepatocellular carcinoma: is inflammation the key?

Shi L, Feng Y, Lin H, Ma R, Cai X.

J Transl Med. 2014 Apr 8;12:93. doi: 10.1186/1479-5876-12-93. Review.

5.

NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer.

Fan Y, Mao R, Yang J.

Protein Cell. 2013 Mar;4(3):176-85. doi: 10.1007/s13238-013-2084-3. Epub 2013 Mar 13. Review.

6.

Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features.

Cheng CW, Su JL, Lin CW, Su CW, Shih CH, Yang SF, Chien MH.

PLoS One. 2013;8(2):e56130. doi: 10.1371/journal.pone.0056130. Epub 2013 Feb 14.

8.

ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer.

Duan Q, Wang X, Gong W, Ni L, Chen C, He X, Chen F, Yang L, Wang P, Wang DW.

PLoS One. 2012;7(2):e31518. doi: 10.1371/journal.pone.0031518. Epub 2012 Feb 16.

9.

Molecular mechanisms underlying hepatocellular carcinoma.

Merle P, Trepo C.

Viruses. 2009 Dec;1(3):852-72. doi: 10.3390/v1030852. Epub 2009 Nov 9.

10.

Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).

Kirovski G, Stevens AP, Czech B, Dettmer K, Weiss TS, Wild P, Hartmann A, Bosserhoff AK, Oefner PJ, Hellerbrand C.

Am J Pathol. 2011 Mar;178(3):1145-52. doi: 10.1016/j.ajpath.2010.11.059. Epub 2011 Jan 28.

11.

Synthesis and identification of new 4-arylidene curcumin analogues as potential anticancer agents targeting nuclear factor-κB signaling pathway.

Qiu X, Du Y, Lou B, Zuo Y, Shao W, Huo Y, Huang J, Yu Y, Zhou B, Du J, Fu H, Bu X.

J Med Chem. 2010 Dec 9;53(23):8260-73. doi: 10.1021/jm1004545. Epub 2010 Nov 11.

12.

NF-kappaB and cancer: how intimate is this relationship.

Prasad S, Ravindran J, Aggarwal BB.

Mol Cell Biochem. 2010 Mar;336(1-2):25-37. doi: 10.1007/s11010-009-0267-2. Epub 2009 Oct 8. Review.

13.

Dysregulation of apoptosis in hepatocellular carcinoma cells.

Fabregat I.

World J Gastroenterol. 2009 Feb 7;15(5):513-20. Review.

14.

Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism.

Murillo MM, Carmona-Cuenca I, Del Castillo G, Ortiz C, Roncero C, Sánchez A, Fernández M, Fabregat I.

Biochem J. 2007 Jul 15;405(2):251-9.

Items per page

Supplemental Content

Write to the Help Desk